Black Diamond Therapeutics (BDTX) Gains from Investment Securities (2019 - 2025)
Black Diamond Therapeutics' Gains from Investment Securities history spans 5 years, with the latest figure at $71000.0 for Q4 2025.
- For Q4 2025, Gains from Investment Securities rose 124.23% year-over-year to $71000.0; the TTM value through Dec 2025 reached $74000.0, changed N/A, while the annual FY2025 figure was $74000.0, N/A changed from the prior year.
- Gains from Investment Securities reached $71000.0 in Q4 2025 per BDTX's latest filing, up from $47000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $293000.0 in Q3 2024 to a low of -$293000.0 in Q4 2024.
- Average Gains from Investment Securities over 3 years is $11333.3, with a median of $20500.0 recorded in 2021.
- The largest YoY upside for Gains from Investment Securities was 124.23% in 2025 against a maximum downside of 124.23% in 2025.
- A 3-year view of Gains from Investment Securities shows it stood at -$6000.0 in 2021, then crashed by 4783.33% to -$293000.0 in 2024, then skyrocketed by 124.23% to $71000.0 in 2025.
- Per Business Quant, the three most recent readings for BDTX's Gains from Investment Securities are $71000.0 (Q4 2025), $47000.0 (Q2 2025), and -$44000.0 (Q1 2025).